Sinae Lifitegrast fabrica, supplementum, Factory

Jiangsu Run'an Pharmaceutical Co, Ltd., subsidiaria omnino possessa de Jiangsu Chiatai Qingjiang Pharmaceutical Co, Ltd., modernus summus tech pharmaceuticus societas specialis in R&D, productionis et venditio fertilitatis ordinandae medicinae et varietatis APIs. Project constructionem mense Novembri 2018 incepit, LIX mu aream obtegens, cum tota obsidione 160 decies Yuan et tota area aedificium 25000 quadratum metrorum.

Praecipuum activum medicamentum pharmaceuticum (API) producta: Hydrochloridum Gemcitabinum, Celecoxib, bromhexinum hydrochloridum, Iguratimod, Apremilast, Citrate Tofactinib, Crisaborole, Urapidil Hydrochloride, Sugammadex Natrium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium Bromidum, Finerenone, Liquidum, Sodium, Finerenonem, Liquidum, Sodium, Garlicinum, Dexmedetomidinem Hydrochloridum, Rocuronium Bromidum, Finerenonem, Liquidum, Sodium, Liquidum, Liquidum, Liquidum, Sodrum, Liquidum, Liquidum, Sodium studemus ut elit mundi genus et opificem generandi productorum per assiduas emendationes et innovationes in technologiarum fiant, et occasiones praeclarum negotium praebeant sodalibus societatibus nostris per orbem. Munus nostrum ad praestantes operas emptores nobis permisit solidas relationes cum sociis nostris toto orbe includere.

View as

CAS#1025967-78-5

Seres operis nomen: Litalast
Sinensis alias: (S)-2-[2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido]- 3-(3-methanesulfonylphenyl) acidum propionicum ;
Anglicus operis nomen: Lifitegrast
CAS#1025967-78-5
Formulae hypotheticae: C29H24Cl2N2O7S
Pondus hypotheticum: 615.4810
Species et possessiones: album ad album-off solid

Lege plus Mitte Inquisitionem

CAS NO.1025967-78-5

Seres operis nomen: Litalast
Sinensis alias: (S)-2-[2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido]- 3-(3-methanesulfonylphenyl) acidum propionicum ;
Anglicus operis nomen: Lifitegrast
CAS NO.1025967-78-5
Formulae hypotheticae: C29H24Cl2N2O7S
Pondus hypotheticum: 615.4810
Species et possessiones: album ad album-off solid

Lege plus Mitte Inquisitionem

CAS 1025967-78-5

Seres operis nomen: Litalast
Sinensis alias: (S)-2-[2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido]- 3-(3-methanesulfonylphenyl) acidum propionicum ;
Anglicus operis nomen: Lifitegrast
CAS 1025967-78-5
Formulae hypotheticae: C29H24Cl2N2O7S
Pondus hypotheticum: 615.4810
Species et possessiones: album ad album-off solid

Lege plus Mitte Inquisitionem

1025967-78-5

Seres operis nomen: Litalast
Sinensis alias: (S)-2-[2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido]- 3-(3-methanesulfonylphenyl) acidum propionicum ;
Anglicus operis nomen: Lifitegrast
Cas# 1025967-78-5
Formulae hypotheticae: C29H24Cl2N2O7S
Pondus hypotheticum: 615.4810
Species et possessiones: album ad album-off solid

Lege plus Mitte Inquisitionem

Lifitegrast API

Seres operis nomen: Litalast
Sinensis alias: (S)-2-[2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido]- 3-(3-methanesulfonylphenyl) acidum propionicum ;
Anglicus operis nomen: Lifitegrast API
Cas# 1025967-78-5
Formulae hypotheticae: C29H24Cl2N2O7S
Pondus hypotheticum: 615.4810
Species et possessiones: album ad album-off solid

Lege plus Mitte Inquisitionem

<1 >

Quiescere potes ex officina nostra emere Lifitegrast in Sinis. Pharmaceutical Run'an professionalis Sinarum Lifitegrast fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.